Alessandro Anselmo, MD, PhD


Specialist in General Surgery
Aggregate Professor of Surgery
Tor Vergata University
Rome, Italy

Biography

He born in Rome, Italy, on 05/16/1965. From 1978 to 1983 attended “Liceo Santa Maria”, High School, in Rome. On 11/09/1989 obtained a degree in Medicine and Surgery, “Tor Vergata” University of Rome (110/110 cum Laude).

From 1991 to 1996 attended the Residency in General Surgery, Surgical Department, “Tor Vergata” University of Rome and on 11/07/1996 he has got the title of Specialist in General Surgery (Thesis: Split Liver Transplantation).

In 2002 achieved PhD in Surgical Physiopathology, (“La Sapienza” University of Rome, Thesis: Vaccine protocol for preventing recurrence in HBV liver transplanted patients); in 2003 Second Level Master in “Organ Transplantation” (Catholic University of Rome); in 2009 FEBS-T Fellow of European Board of Surgery (Division of Transplantation, modules 1, 2, 4); in 2013 PhD in Organ Transplantation (“Tor Vergata” University of Rome).

From 2003 to present he is consultant surgeon at Department of Surgery, HPB and Transplant Surgery Unit, Policlinico Tor Vergata, Rome, Italy.

Dr. Alessandro Anselmo is a liver and kidney transplant surgeon with expertise and passion in oncologic HPB surgery. He have also strong interest in new technologies applied to minimally invasive liver and pancreatic surgery. Author of 60 indexed publications and surgical videos.

Organizer, Presenter and Moderator in may International and national meetings.

Research Interest

His research interest key words: Liver surgery, Laparoscopy, Liver transplant, Kidney transplant, Immunosuppression, Hepatocellular carcinoma, Cholangiocellular carcinoma, Liver resection, Cirrhosis, Liver tumor, Pancreatic cancer, Pancreatitis.

Scientific Activities

Publications

1. Ielpo B, Giuliani A, Sanchez P, et al. Laparoscopic glissonean pedicle approach: Step by step video description of the technique from different centres (with video). Updates Surg. 2022. doi: 10.1007/s13304-021-01219-9
2. Anselmo A, Siragusa L, Sensi B, et al. High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: A case report with long-term follow-up. Obes Res Clin Pract. 2022; 16(1): 91-94. doi: 10.1016/j.orcp.2022.01.001
3. Manzia TM, Gazia C, Lenci I, et al. Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor. Am J Transplant. 2021; 21(7): 2600-2604. doi: 10.1111/ajt.16548
4. Ferri F, Milana M, Abbatecola A, et al. Electronic outpatient referral system for liver transplant improves appropriateness and allows first visit triage. Clin Gastroenterol Hepatol. 2021; S1542-3565(21)01091-0. doi: 10.1016/j.cgh.2021.10.005
5. Anselmo A, Sforza D, Pellicciaro M, et al. Laparoscopic isolated caudate lobectomy of two symptomatic familiar giant liver hemangiomas, case reports and literature review. Journal of Men’s Health. 2021; 17(4): 310-315. doi: 10.31083/jomh.2021.109
6. Del Vecchio Blanco G, Palmieri G, et al. Scandinavian factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumors. Scand J Gastroenterol. 2021; 56(4): 498-504. doi: 10.1080/00365521.2021.1880628
7. Manzia TM, Quaranta C, Filingeri V, et al. Feasibility and cost effectiveness of ambulatory laparoscopic cholecystectomy. A retrospective cohort study. Ann Med Surg (Lond). 2020; 55: 56-61. doi: 10.1016/j.amsu.2020.04.036
8. Manzia TM, Tariciotti L, Angelico R, Toti L, Anselmo A, Tisone G. Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis. Int J Surg Case Rep. 2015; 6C: 222-225. doi: 10.1016/j.ijscr.2014.10.037
9. Angelico M, Nardi A, Romagnoli R, et al. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. Dig Liver Dis. 2014; 46(4): 340-347. doi: 10.1016/j.dld.2013.11.004
10. Anselmo A, Prezioso C, Saccà FA, et al. Kidney graft failure induced by BKPyV replication despite a strong reduction of the immunosuppressive therapy. J Med Virol. 2019; 91(9): 1698-1701. doi: 10.1002/jmv.25458
11. Del Vecchio Blanco G, Gesuale C, et al. Contrast-enhanced endoscopic ultrasound diagnosis of the intraductal papillary mucinous neoplasm. Clin J Gastroenterol. 2020; 13(1): 120-126. doi: 10.1007/s12328-019-01008-3
12. Aldrighetti L, Boggi U, Falconi M, et al. Perspectives from Italy during the COVID-19 pandemic: Nationwide survey-based focus on minimally invasive HPB surgery. Updates Surg. 2020; 72(2): 241-247. doi: 10.1007/s13304-020-00815-5
13. Sforza D, Parente A, Pellicciaro M, et al. Prostate cancer recurrence in kidney transplant recipient 15 years after radical prostatectomy: A case report. Transplant Proc. 2019; 51(9): 2995-2997. doi: 10.1016/j.transproceed.2019.04.098
14. Manzia TM, Gazia C, Lenci I, et al. Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor. Am J Transplant. 2021; 21(7): 2600-2604. doi: 10.1111/ajt.16548
15. Sforza D, Iaria G, Petagna L, et al. Switch from twice-daily tacrolimus to once-daily, prolonged-release tacrolimus in kidney transplantation: Long-term outcome. Transplant Proc. 2019; 51(1): 140-142. doi: 10.1016/j.transproceed
16. Anselmo A, Iaria G, Pellicciaro M, et al. Native nephrectomy in patients with autosomal dominant polycystic kidney disease evaluated for kidney transplantation. Transplant Proc. 2019; 51(9): 2914-2916. doi: 10.1016/j.transproceed.2019.08.010
17. Rovella V, Scimeca M, Giannini E, et al. Morphological evaluation of sympathetic renal innervation in patients with autosomal dominant polycystic kidney disease. J Nephrol. 2020; 33(1): 83-89. doi: 10.1007/s40620-019-00612-3
18. Mauriello A, Rovella V, Borri F, et al. Hypertension in kidney transplantation is associated with an early renal nerve sprouting. Nephrol Dial Transplant. 2017; 32(6): 1053-1060. doi: 10.1093/ndt/gfx069
19. Del Vecchio Blanco G, Palmieri G, Giannarelli D, et al. Factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumors. Scand J Gastroenterol. 2021; 56(4): 498-504. doi: 10.1080/00365521.2021.1880628
20. Tariciotti L, Manzia TM, Sforza D, Anselmo A, Tisone G. Everolimus and advagraf Ab initio in combined liver and kidney transplant with donor-specific antibodies: A case report. Transplant Proc. 2016; 48(9): 3109-3111. doi: 10.1016/j.transproceed.2016.07.021
21. Mauriello A, Rovella V, Anemona L, et al. Increased sympathetic renal innervation in hemodialysis patients is the anatomical substrate of sympathetic hyperactivity in end-stage renal disease. J Am Heart Assoc. 2015; 4(12): e002426. doi: 10.1161/JAHA.115.002426
22. Manzia TM, Tariciotti L, Angelico R, Toti L, Anselmo A, Tisone G. Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis. Int J Surg Case Rep. 2014; 6C: 222-225. doi: 10.1016/j.ijscr.2014.10.037
23. Orlacchio A, Chegai F, Anselmo A, et al. Kidney transplant: Usefulness of real-time elastography (RTE) in the diagnosis of graft interstitial fibrosis. Ultrasound Med Biol. 2014; 40(11): 2564-72. doi: 10.1016/j.ultrasmedbio.2014.06.002
24. Angelico M, Cillo U, Fagiuoli S, et al. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. Dig Liver Dis. 2014; 46(4): 340-347. doi: 10.1016/j.dld.2013.11.004
25. Sforza D, Iaria G, Tariciotti L, et al. Deep vein thrombosis as debut of cytomegalovirus infection associated with type II cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report. Transplant Proc. 2013; 45(7): 2782-2784. doi: 10.1016/j.transproceed.2013.07.004
26. Manzia TM, Angelico R, Toti L, et al. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports. Transplant Proc. 2011; 43(4): 1181-1183. doi: 10.1016/j.transproceed.2011.01.129
27. Iaria G, Sforza D, Angelico R, et al. Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. Transplant Proc. 2011; 43(4): 1028-1029. doi: 10.1016/j.transproceed.2011.01.130
28. Avolio AW, Agnes S, Lirosi MC, et al. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant. 2011; 11(12): 2724-2736. doi: 10.1111/j.1600-6143.2011.03732.x
29. Anselmo A, Rossi P, De Mayo A, et al. Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. Minerva Chir. 2011; 66(5): 495-499.
30. Toti L, Manzia TM, Romano P, et al. Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. Transpl Int. 2010; 23(1): 114-115. doi: 10.1111/j.1432-2277.2009.00908.x
31. Lionetti R, Tisone G, Palmieri G, et al. Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression. Dig Liver Dis. 2010; 42(4): 297-303. doi: 10.1016/j.dld.2009.08.008
32. Manzia TM, Gravante G, Toti L, et al. Management of spermatic cord liposarcoma in renal transplant recipients: Case report. Transplant Proc. 2010; 42(4): 1355-1357. doi: 10.1016/j.transproceed.2010.03.043
33. Gentileschi P, Venza M, Benavoli D, et al. Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: A case report. Obes Surg. 2009; 19(10): 1460-1463. doi: 10.1007/s11695-009-9877-8
34. Iaria G, Anselmo A, De Luca L, et al. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation: Case reports. Transplant Proc. 2007; 39(6): 2036-2037. doi: 10.1016/j.transproceed.2007.05.046
35. Iaria G, Iorio B, Anselmo A, et al. Graft failure due to hemolytic uremic syndrome recurrence. Transplant Proc. 2006; 38(4): 1020-1021. doi: 10.1016/j.transproceed.2006.02.019
36. Baiocchi L, Angelico M, De Luca L, et al. Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans. Transpl Int. 2006; 19(5): 389-395. doi: 10.1111/j.1432-2277.2006.00296.x
37. Baiocchi L, Tisone G, Falasca L, et al. Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: A biochemical and ultra-structural study in humans. Hepatol Res. 2006; 35(3): 215-221. doi.org/10.1016/j.hepres.2006.03.001
38. Tisone G, Orlando G, Cardillo A, et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol. 2006; 44(4): 702-709. doi: 10.1016/j.jhep.2005.11.047
39. Orlando G, Cardillo A, Anselmo A, et al. Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. Transplant Proc. 2005; 37(6): 2629-2631. doi: 10.1016/j.transproceed.2005.06.041
40. Manzia TM, De Liguori Carino N, et al. Use of mycophenolate mofetil in liver transplantation: A literature review. Transplant Proc. 2005; 37(6): 2616-2617. doi: 10.1016/j.transproceed.2005.06.073
41. Gandini R, Konda D, Tisone G, Pipitone V, Anselmo A, Simonetti G. Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. Cardiovasc Intervent Radiol. 2005; 28(6): 828-831. doi: 10.1007/s00270-004-0201-7
42. Muzi F, Orlando G, Ielpo B, et al. Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. Transplant Proc. 2005; 37(4): 1705-1707. doi: 10.1016/j.transproceed.2005.03.077
43. Falasca L, Tisone G, Palmieri G, et al. Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: A pilot study in transplant recipients. Transplantation. 2001; 71(9): 1268-1276. doi: 10.1097/00007890-200105150-00015
44. Iaria G, Tisone G, Pisani F, et al. High-pressure perfusion versus gravity perfusion in liver harvesting: Results from a prospective randomized study. Transplant Proc. 2001; 33(1-2): 957-958. doi: 10.1016/S0041-1345(00)02284-3
45. Falasca L, Tisone G, Orlando G, et al. Tauroursodeoxycholate reduces ischemic damage in human allografts: A biochemical and ultrastructural study. Transplant Proc. 2000; 32(1): 49-50. doi: 10.1016/S0041-1345(99)00872-6
46. Tisone G, Orlando G, Vennarecci G, et al. Spontaneous resolution of severe acute rejection in liver transplantation. Transplant Proc. 1999; 31(8): 3164-3166.
47. Tisone G, Mercadante E, Dauri M, et al. Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: A prospective randomized study. Transplant Proc. 1999; 31(8): 3162-3163
48. Angelico M, Tisone G, Baiocchi L, et al. One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation. Ital J Gastroenterol Hepatol. 1999; 31(6): 462-468.
49. Tisone G, Angelico M, Palmieri G, et al. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation. 1999; 67(10): 1308-1313. doi: 10.1097/00007890-199905270-00003
50. Tisone G, Baiocchi L, Orlando G, et al. Hepatitis C reinfection after liver transplantation in relation to virus genotype. Transplant Proc. 1999; 31(1-2): 490-491.
51. Tisone G, Angelico M, Palmieri G, et al. Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: Preliminary results of a randomized study. Transpl Int. 1998; 11 Suppl 1: S267-S269. doi: 10.1007/s001470050475
52. Tisone G, Vennarecci G, Pisani F, et al. Reduced acute rejection and side effects with neoral in liver transplantation. Transplant Proc. 1998; 30(4): 1430-1431. doi: 10.1016/s0041-1345(98)00302-9
53. Tisone G, Romagnoli J, Vennarecci G, et al. Is donor age a risk factor for poor graft function after orthotopic liver transplantation? Transplant Proc. 1997; 29(7): 2825-2826. doi: 10.1016/s0041-1345(97)00693-3
54. Tisone G, Angelico M, Baiocchi L, et al. Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. Transplant Proc. 1996; 28(3): 1655-1656.
55. Baiocchi L, Tisone G, Nistri A, et al. Sequential changes in serum and biliary bile acids after liver transplantation. Transplant Proc. 1995; 27(6): 3503-3504.
56. Milito G, Cortese F, Anselmo A, Casciani U. Treatment of hemorrhoidal peduncles with diathermy probe. Ann Ital Chir. 1995; 66(6): 801-803.
57. Filingeri V, Rosati R, Sconocchia G, et al. Synergism between cyclosporin and gangliosides in anti-rejection therapy. Experimental in vivo model. Minerva Chir. 1995; 50(3): 275-278.
58. Filingeri V, Rosati R, Barletta N, Anselmo A, Vennarecci G, Casciani CU. The current role of microsurgery in the therapy of idiopathic varicocele. Minerva Chir. 1994; 49(5): 469-473.
59. Pepe N, Actis Dato GM, Vennarecci G, Anselmo A. Office surgery: Organization, legislative, and medico-legal problems. Personal experience. Minerva Chir. 1993; 48(21-22): 1361-1366.